CymaBay Therapeutic (CBAY) PT Lowered to $10 at Oppenheimer
Tweet
Share
E-mailGet Alerts CBAY Hot Sheet
Price: $32.48 --0%
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on CymaBay Therapeutic (NASDAQ: CBAY) to $10.00 (from $12.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades China Literature (772:HK) (CHLLF) to Neutral
- AUTO1 Group SE (AG1:GR) (ATOGF) PT Raised to EUR39 at Citi
- AENA SME SA (AENA:SM) (ANNSF) PT Raised to EUR28 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
